136 related articles for article (PubMed ID: 36180948)
1. Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation.
Katada Y; Nakagawa S; Itohara K; Suzuki T; Kato R; Endo H; Sugimoto M; Yonezawa A; Nakagawa T; Ohsumi A; Nakajima D; Date H; Terada T
J Pharm Health Care Sci; 2022 Oct; 8(1):25. PubMed ID: 36180948
[TBL] [Abstract][Full Text] [Related]
2. Higher tacrolimus trough levels and time in the therapeutic range are associated with the risk of acute rejection in the first month after renal transplantation.
Nguyen TVA; Nguyen HD; Nguyen TLH; Le VT; Nguyen XK; Tran VT; Le DT; Ta BT
BMC Nephrol; 2023 May; 24(1):131. PubMed ID: 37158838
[TBL] [Abstract][Full Text] [Related]
3. Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation.
Song T; Yin S; Jiang Y; Huang Z; Liu J; Wang Z; Li L; Zeng J; Fan Y; Wang X; Li X; Lin T
Front Immunol; 2019; 10():2912. PubMed ID: 31921171
[No Abstract] [Full Text] [Related]
4. Tacrolimus time in therapeutic range and long-term outcomes in heart transplant recipients.
Adie SK; Bitar A; Konerman MC; Dorsch MP; Andrews CA; Pogue K; Park JM
Pharmacotherapy; 2022 Feb; 42(2):106-111. PubMed ID: 34882822
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation.
Santeusanio AD; Gu A; Weinberg AD; Moon J; Iyer KR
Clin Transplant; 2021 Jun; 35(6):e14291. PubMed ID: 33740822
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score-Matched Analysis.
Yin S; Song T; Jiang Y; Li X; Fan Y; Lin T
Ther Drug Monit; 2019 Jun; 41(3):308-316. PubMed ID: 31083041
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal.
Pierce DR; West-Thielke P; Hajjiri Z; Gaitonde S; Tzvetanov I; Benedetti E; Lichvar AB
Transplant Direct; 2021 Jun; 7(6):e698. PubMed ID: 34036168
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantation.
Kao CC; Segraves J; Parulekar AD
Eur J Clin Pharmacol; 2021 Jan; 77(1):63-69. PubMed ID: 32803287
[TBL] [Abstract][Full Text] [Related]
9. Impact of a pharmacist-led tacrolimus management protocol in the outpatient setting.
Owen K; Winters H; Palettas M; Witkowsky O
J Am Pharm Assoc (2003); 2022; 62(6):1912-1918. PubMed ID: 35843802
[TBL] [Abstract][Full Text] [Related]
10. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
11. Early Monitoring and Subsequent Gain of Tacrolimus Time-In-Therapeutic Range May Improve Clinical Outcomes After Living Kidney Transplantation.
Yin S; Huang Z; Wang Z; Fan Y; Wang X; Song T; Lin T
Ther Drug Monit; 2021 Dec; 43(6):728-735. PubMed ID: 34780391
[TBL] [Abstract][Full Text] [Related]
12. Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection.
Borobia AM; Romero I; Jimenez C; Gil F; Ramirez E; De Gracia R; Escuin F; Gonzalez E; Sansuán AJ
Ther Drug Monit; 2009 Aug; 31(4):436-42. PubMed ID: 19494792
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation.
Sohn YM; Ko RE; Park HJ; Choo E; Jung M; Lee S; Jeon K
J Thorac Dis; 2023 Jun; 15(6):3431-3436. PubMed ID: 37426157
[TBL] [Abstract][Full Text] [Related]
14. Effect of Tacrolimus Time in Therapeutic Range on Postoperative Recurrence in Patients Undergoing Liver Transplantation for Liver Cancer.
Lao Q; Wu X; Zheng X; Hu J; Huang S; Li D; Du Y; Yang N; Zhu H
Ther Drug Monit; 2024 Feb; 46(1):42-48. PubMed ID: 37315150
[TBL] [Abstract][Full Text] [Related]
15. Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients.
Leino AD; Park JM; Pasternak AL
Pharmacotherapy; 2021 Aug; 41(8):649-657. PubMed ID: 34129685
[TBL] [Abstract][Full Text] [Related]
16. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation.
Staatz C; Taylor P; Tett S
Nephrol Dial Transplant; 2001 Sep; 16(9):1905-9. PubMed ID: 11522877
[TBL] [Abstract][Full Text] [Related]
17. Association Between Time-in-Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant.
Baker WL; Steiger S; Martin S; Patel N; Radojevic J; Darsaklis K; O'Bara L; Kutzler H; Dougherty J; Feingold A; Hammond J; Fusco D; Gluck JA
Pharmacotherapy; 2019 May; 39(5):609-613. PubMed ID: 30892740
[TBL] [Abstract][Full Text] [Related]
18. Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients.
Arreola-Guerra JM; Alberú J; Chew-Wong A; Macias DM; Hernández-Rosales J; Zuñiga-Macías L; Delgadillo-Castañeda R; Ricalde-Ríos G; Haro-Alcalde F; Villafán-Bernal JR; Ramos-Medellín CL; Reyes-Acevedo R
Clin Transplant; 2019 Dec; 33(12):e13749. PubMed ID: 31691354
[TBL] [Abstract][Full Text] [Related]
19. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
Wang XZ; Jin ZK; Tian XH; Xue WJ; Tian PX; Ding XM; Zheng J; Li Y; Jing X; Luo ZZ
Transpl Immunol; 2014 Jan; 30(1):18-23. PubMed ID: 24211610
[TBL] [Abstract][Full Text] [Related]
20. Higher Variability of Tacrolimus Trough Level Increases Risk of Acute Rejection in Kidney Transplant Recipients.
Huang CT; Shu KH; Ho HC; Wu MJ
Transplant Proc; 2016; 48(6):1978-80. PubMed ID: 27569931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
